Ha Tay Pharmaceutical JSC Valuation

Is DHT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DHT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: DHT (₫80200) is trading above our estimate of fair value (₫55149.14)

Significantly Below Fair Value: DHT is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for DHT?

Key metric: As DHT is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for DHT. This is calculated by dividing DHT's market cap by their current earnings.
What is DHT's PE Ratio?
PE Ratio98.8x
Earnings₫66.84b
Market Cap₫6.75t

Price to Earnings Ratio vs Peers

How does DHT's PE Ratio compare to its peers?

The above table shows the PE ratio for DHT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average20.6x
IMP Imexpharm
29.5x31.9%₫6.4t
DBD Binh Dinh Pharmaceutical and Medical Equipment
19.5xn/a₫4.6t
DHG DHG Pharmaceutical
16.2x11.8%₫13.1t
TRA Traphaco
17xn/a₫3.1t
DHT Ha Tay Pharmaceutical JSC
98.8xn/a₫6.8t

Price-To-Earnings vs Peers: DHT is expensive based on its Price-To-Earnings Ratio (98.8x) compared to the peer average (20.6x).


Price to Earnings Ratio vs Industry

How does DHT's PE Ratio compare vs other companies in the Asian Pharmaceuticals Industry?

11 CompaniesPrice / EarningsEstimated GrowthMarket Cap
DHT 98.8xIndustry Avg. 24.0xNo. of Companies73PE020406080100+
11 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: DHT is expensive based on its Price-To-Earnings Ratio (98.8x) compared to the Asian Pharmaceuticals industry average (24x).


Price to Earnings Ratio vs Fair Ratio

What is DHT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DHT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio98.8x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate DHT's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies